Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers...
16 insider purchases on record · latest filing 2026-05-14.
Insiders have also filed 977 sale transactions at MYGN.